Find a Trial

Trial Summary


Protocol No.PHO-COG-ANBL19P1
StatusOPEN TO ACCRUAL
Principal InvestigatorBatra, Sandeep
ScopeNational
PhasePhase II
Age GroupChildren
TitleANBL19P1; A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk Neuroblastoma
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactHeather Claussen, Phone:
    Pager:
    Email: heclauss@iupui.edu